Mate Fertility, Inc.

Based in the US, Mate Fertility, Inc. operates in the fertility sector, providing advanced solutions to assist individuals and couples facing conception challenges through personalized treatment plans and innovative reproductive technologies. Mate Fertility, Inc. was founded in 2020 in Los Angeles, US.

The company specializes in fertility solutions, offering in vitro fertilization (IVF), egg freezing, and thorough fertility assessments. Gabriel Bogner is the founder, and Traci Keen serves as the CEO. In January 2023, Mate Fertility raised USD 5. 2 mn in Series A funding, led by Struck Capital Management, with participation from various investors, marking a total of 3 deals completed by the company.

Mate Fertility specializes in providing advanced fertility solutions designed to assist individuals and couples facing challenges in conceiving. The company's core offerings include a range of personalized treatment plans that leverage innovative reproductive technologies, such as in vitro fertilization (IVF), egg freezing, and comprehensive fertility assessments. These services aim to address various infertility issues by providing tailored care that enhances the chances of successful conception. The primary user base includes individuals looking to build families, as well as couples experiencing fertility issues.

Geographically, Mate Fertility targets markets within North America and Europe, catering to clients who seek both in-clinic services and telehealth consultations for greater accessibility. Mate Fertility generates revenue through a structured service model that primarily involves direct-to-consumer transactions. Clients typically engage with the company through comprehensive fertility packages, which may include initial consultations, diagnostic testing, and ongoing treatment plans. Pricing structures are designed to accommodate various needs, with some flagship services available as bundled packages that offer significant savings compared to individual treatments.

The company also provides financing options to help patients manage costs effectively. Additionally, partnerships with healthcare providers may enhance revenue streams by integrating Mate Fertility’s services into broader healthcare offerings. In January 2023, Mate Fertility raised USD 5. 2 mn in Series A funding, which will be utilized to expand its business, recruit additional clinicians, support marketing efforts, and launch new clinics in Pittsburgh and Northern Virginia.

The company is focused on enhancing its product offerings and expanding into new geographic regions to better serve clients.